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OBJECTIVES: To analyze diffusion-weighted imaging (DWI) findings of meningiomas and to compare them with tumor
grade, cell count, andproliferation index and to test apossibility of useof apparent diffusion coefficient (ADC) todifferentiate
benign from atypical/malignant tumors. METHODS: Forty-nine meningiomas were analyzed. DWI was done using a
multislice single-shot echo-planar imaging sequence. A polygonal region of interest was drawn on ADCmaps around the
margin of the lesion. In all lesions, minimal ADC values (ADCmin) and mean ADC values (ADCmean) were estimated.
Normalized ADC (NADC) was calculated in every case as a ratio ADCmean meningioma/ADCmean white matter. All
meningiomaswere surgically resected and analyzedhistopathologically. The tumor proliferation indexwasestimatedonKi-
67 antigen–stained specimens. Cell density was calculated. Collected data were evaluated by means of descriptive
statistics. Analyses of ADC/NADC values were performed by means of two-sided t tests. RESULTS: The mean ADCmean
value was higher in grade I meningiomas in comparison to grade II/III tumors (0.96 vs 0.80 × 10−3 mm2s−1, P = .006).
Grade II/IIImeningiomasshowed lowerNADCvalues in comparison tograde I tumors (1.05 vs1.26,P=.015). Therewasno
significant difference in ADCmin values between grade I and II/III tumors (0.69 vs 0.63 × 10
−3 mm2s−1, P = .539). The
estimatedcell count varied from486 to2091 (meanvalue,1158.20±333.74;medianvalue,1108). Therewerenosignificant
differences in cell count between grade I and grade II/III tumors (1163.93 vs 1123.86 cells, P= .77). The mean level of the
proliferation indexwas4.78±5.08%, the rangewas1%to18%, and themedian valuewas2%. Theproliferation indexwas
statistically significant higher in grade II/IIImeningiomas in comparison tograde I tumors (15.43%vs3.00%,P=.001). Ki-67
was negatively associated with ADCmean (r=−0.61, P b .001) and NADC (r=−0.60, P b .001). No significant correlations
between cell count and ADCmean (r=−0.20, P= .164) or NADC (r=−0.25, P= .079) were found.
ADCmin correlated statistically significant with cell count (r = −0.44, P = .002) but not with Ki-67 (r = −0.22, P = .129).
Furthermore, the association between ADCmin and cell count was stronger in grade II/III tumors (r = −0.79, P = .036)
versusgrade Imeningiomas (r=−0.41,P=.008). AnADCmean valueof less than0.85×10
−3mm2s−1wasdeterminedas
the threshold in differentiating between grade I and grade II/III meningiomas (sensitivity 72.9%, specificity 73.1%, accuracy
73.0%). The positive and negative predictive values were 33.3% and 96.8%, respectively. The same threshold ADCmean© 2015 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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518 DWI and Histological Parameters in Meningioma Surov et al. Translational Oncology Vol. 8, No. 6, 2015valuewasused in differentiating between tumorswithKi-67 level≥5%andmeningiomaswith lowproliferation index (Ki-67
b5%). This threshold yielded a sensitivity of 70.6%, a specificity of 81.2%, and an accuracy of 77.6%. The positive and
negative predictive values were 66.6% and 83.9%, respectively. CONCLUSIONS: Grade II/III tumors had lower ADCmean
values than grade Imeningiomas. ADCmean correlated negatively with tumor proliferation index and ADCmin with tumor cell
count. These associationswere different in severalmeningiomas. ADCmean can be used for distinguishing between benign
and atypical/malignant tumors.
Translational Oncology (2015) 8, 517–523Introduction
According to the literature, diffusion-weighted imaging (DWI) provides
information regarding tissue microstructure [1–6]. Furthermore, it has
been shown that DWI can be used to distinguish malignant from benign
tumors [1,4,5]. As reported previously, malignant tumors showed lower
apparent diffusion coefficient (ADC) values in comparison to benign
lesions [1,3]. In addition, as suggested in previous reports, ADC values
under 1.00 × 10−3 mm2s−1 were suspicious for a malignancy [1].
However, according to the literature, some benign lesions had also very
low ADC values and can mimic malignancies [7–9]. For example, ADC
values of nasopharyngeal adenoid hypertrophy varied from 0.36 to 0.84 ×
10−3 mm2s−1 with a median value of 0.59 ± 0.11 × 10−3 mm2s−1 [7].
In addition, in the study of Ikeda et al., the mean ADC of
Warthin tumors was significantly lower than that of malignant parotid
tumors [8]. Furthermore, it is well known that cholesteatomas also has low
ADC values [9].
As reported previously, ADC values correlated well with cell count of the
investigated lesions [2,6,9]. For instance, Driessen et al. reported that ADC
was significantly and inversely correlatedwith cell density (r = −0.57,P = .02)
in laryngeal and hypopharyngeal carcinomas [6]. In addition, Schnapauff
et al. identified a linear relation between tumor cellularity and ADC in soft
tissue sarcoma with a Pearson correlation coefficient of −0.88 [2]. Similar
results were reported also for prostatic cancer and renal malignancies [10,11].
However, Wu et al. found no correlation between the ADC value and the
tissue cellularity in patients with diffuse large B-cell lymphoma and follicular
lymphoma [12]. Furthermore, according to another report, the ADC value
for breast cancer did not significantly correlate with cancer cellularity but did
correlate with histological types [13].
According to the literature, ADC can be used as a marker to predict
response to therapy in different malignant diseases [14–16].
There were several reports describing features of meningiomas on
DWI; however, the provided data were inconsistent [17–20]. Whereas
some authors found an association between ADC and histological
parameters of meningiomas [18,19,21], others did not [17,20]. In
addition, in the analysis of Ginat et al., no association between ADC
and Ki-67 level was found [22], whereas other authors reported a
statistically significant correlation between these parameters [21].
Because of the fact that meningioma is the most frequent
intracranial tumor and is often an incidental finding on magnetic
resonance imaging (MRI), it is important to correctly estimate tumor
grade and proliferation potential on imaging [21].
Therefore, the purpose of this study was to analyze DWI findings of
meningiomas and to compare them with different histological
parameters such as tumor grade and subtypes, cell count, and
proliferation index and to test a possibility of ADC use to differentiate
benign from matypical/malignant tumors.Materials and Methods
This study was approved by the institutional review board (Martin
Luther University medical ethic committee).
Patients and Imaging
Images of all meningiomas resected at our institution in the time
period from 2006 to 2013 were analyzed retrospectively. Only
tumors which were investigated by DWI with good quality of images
were included into the study. Tumors below 10 mm in diameter,
calcified meningiomas, and tumors with artifacts on DWI/ADC map
were excluded from the study. After a thorough inspection of the
images, 49 tumors were adopted for further analysis. These tumors
were found in 38 women and 11 men with a mean age of 59.0 years
(median age, 63 years; range, 20-82 years).
In all patients, MRI of the head was performed using a 1.5-T device
(Magnetom Vision Sonata Upgrade, Siemens, Erlangen, Germany).
The imaging protocol included axial T2-weighted fat-suppressed short-
tau-inversion-recovery images and axial T1-weighted (T1w) spin echo
images before and after intravenous application of contrast medium
(gadopentate dimeglumine, Magnevist, Bayer Schering Pharma, Lever-
kusen, Germany). DWI was done using a multislice single-shot
echo-planar imaging sequence (repetition time/echo time: 5900/96
milliseconds; field of view: 250×250mm; slice thickness: 5mm; acquisition
matrix: 128 × 128), with b values of 0, 500, and 1000 s/mm2. ADC maps
were automatically generated by the implemented software according to the
following equation: ADC (mm2s−1) = [ln(S0/S1000)] / 1000, where S0 and
S1000 represent the signal intensities of the images. The slice with the
largest diameter of meningioma was selected for ADC calculation. In
this image. a polygonal region of interest (ROI) as large as possible was
manually drawn on ADCmaps around the margin of the lesion (whole
lesion measurement) without risking partial volume effects. ROIs were
placed to avoid cystic and necrotic areas as well as large vessels of the
tumors. The position of every ROI was automatically placed also on all
other images (T2 weighted, and pre- and postcontrast T1w). In all
lesions, minimal ADC values (ADCmin) and mean ADC values
(ADCmean) were estimated. In addition, ROIs were drawn in the
normal white matter of the contralateral hemisphere (ADC white
matter). Normalized ADC (NADC) was calculated in every case as a
ratio ADCmean meningioma/ADCmean white matter.
All images were analyzed retrospectively by one radiologist
(A.S., 11 years of radiological experience).
Histopathological Analysis
All 49 meningiomas were surgically resected and analyzed
histopathologically. Tumor grading was classified according to the
World Health Organization [23].
Figure 1. MRI and pathological findings in grade 1 meningioma. (a)
Postcontrast T1w image showing a large tumor with marked enhance-
ment. (b)ADCmapof the tumor.ADCmean value is0.79×10
−3mm2s−1;
ADCmin is 0.54 × 10
−3 mm2s−1. ADCmean value of the normal white
matter of the contralateral hemisphere is 0.68 × 10−3 mm2s−1,
yielding an NADC value of 1.16. (c) Histological investigation after
surgical resection confirmed a meningothelial meningioma (hema-
toxilin and eosin stain). Cell count is 1090. Immunohistochemical
stain (MIB-1 monoclonal antibody). Ki-67 index = 2%.
Figure 2.MRI and pathological findings in grade II meningioma. (a)
Postcontrast T1w image showing a large tumor with markedly
homogeneous enhancement. (b) ADC map of the tumor. ADCmean
value is 0.83 × 10−3 mm2s−1; ADCmin is 0.72 × 10
−3 mm2s−1.
ADCmean value of the normal white matter of the contralateral
hemisphere is 0.79 × 10−3 mm2s−1, yielding an NADC value of
1.05. (c) Histological findings after surgical resection (hematoxilin
and eosin stain). Cell count is 1108. (d) Immunohistochemical stain
(MIB-1 monoclonal antibody). Ki-67 index = 18%.
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antigen–stained specimens by using MIB-1 monoclonal antibody
(DakoCytomation, Denmark) as reported previously [24,25].
Overall, 5 high-power fields (0.16 mm2 per field) with amagnification of ×400 were analyzed. The area with the highest
number of positive tumor nuclei was selected.
Cell density was calculated in every case as an average cell count per
5 high-power fields (×400; 0.16 mm2 per field). All images were
analyzed by using a research microscope, Jenalumar, with camera
Diagnostic Instruments 4.2.
Table 1. Investigated Parameter in Meningioma
Parameter M ± SD Median Range
ADCmin, ×10
−3 mm2s−1 0.68 ± 0.14 0.67 0.33-1.2
ADCmean, ×10
−3 mm2s−1 0.94 ± 0.20 0.9 0.71-1.78
NADC 1.23 ± 0.26 1.16 0.9-2.17
Cell count 1158.20 ± 333.74 1108 486-2091
Ki-67, % 4.78 ± 5.08 2 1-18
Figure 3. Comparison of ADC/NADC values between meningiomas.
(a) ADCmean values in grade I and II/III meningiomas. Grade I tumors
showed higher mean ADCmean value in comparison to grade II/III
tumors (0.96 vs 0.80 × 10−3 mm2s−1, P= .006). (b) NADC values in
grade I and II/III meningiomas. Grade I tumors showed higher NADC
values in comparison to grade II/III tumors (1.26 vs 1.05, P = .015).
(c) ADCmin values in grade I and II/III meningiomas. There was no
significant difference in ADCmin values between grade I and II/III
tumors (0.69 vs 0.63 × 10−3 mm2s−1, P = .539).
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For statistical analysis, the SPSS statistical software package was
used (SPSS 17.0, SPSS Inc., Chicago, IL). All measurements were
non-normally distributed according to Kolmogorov-Smirnov test.
Collected data were evaluated by means of descriptive statistics
(absolute and relative frequencies). Categorical variables were
expressed as percentages. Analyses of ADC and NADC values were
performed by means of two sided Mann-WhitneyU tests. P values b .05
were taken to indicate statistical significance in all instances [26].
Spearman's correlation coefficient was used to analyze the association
between ADC/NADC values and histological parameters.
Furthermore, the receiver operating characteristic (ROC) curve
was used to evaluate the diagnostic ability of the ADC value to
differentiate between benign and grad II/III meningiomas. The
optimal cutoff value was determined according to the Youden index.
In addition, sensitivity, specificity, negative and positive predictive
values, accuracy, and area under the curve value were calculated for
the diagnostic procedures.
Results
In most cases (n = 42, 86%), benign tumors (i.e., World Health
Organization grade I) were diagnosed. Most frequently (n = 25, 51%),
meningothelial meningiomas followed by transitional meningiomas
(n = 11, 22%)were identified (Figure 1). Grade II tumors were found in
six patients (12%) and grade III in one case (2%) (Figure 2).
The estimated ADCmean values of meningiomas ranged from 0.71
to 1.78 × 10−3 mm2s−1 with a median value of 0.9 × 10−3 mm2s−1;
the mean value was 0.94 ± 0.20 × 10−3 mm2s−1 (Figures 1 and 2).
The mean value of ADCmin was 0.68 ± 0.14 × 10
−3 mm2s−1, median
value was 0.67 × 10−3 mm2s−1, and range was 0.33 to 1.2 × 10−3
mm2s−1 (Table 1). The mean NADC value was 1.23 ± 0.26, and the
median value was 1.16, ranging from 0.9 to 2.17.
The mean ADCmean value was higher in grade I meningiomas in
comparison to grade II/III tumors (0.96 vs 0.80 × 10−3 mm2s−1, P =
.006) (Figure 3a). Grade II/III meningiomas showed lower NADC
values in comparison to grade I tumors (1.05 vs 1.26, P = .015)
(Figure 3b). There was no significant difference in ADCmin values
between grade I and II/III tumors (0.69 vs 0.63 × 10−3 mm2s−1, P =
.539) (Figure 3c).
In addition, no significant differences in ADCmean (0.90 vs 0.96 ×
10−3 mm2s−1, P = .074) and ADCmin (0.65 vs 0.73 × 10
−3 mm2s−1,
P = .054) values were identified between meningothelial and
transitional meningiomas.
The estimated cell count varied from 486 to 2091 (mean value,
1158.20 ± 333.74; median value, 1108) (Table 1). There were no
significant differences in cell count between grade I and grade II/III
tumors (1163.93 vs 1123.86 cells, P = .77).
The mean level of the proliferation index was 4.78 ± 5.08%, the
range was 1% to 18%, and the median value was 2%. The
proliferation index was statistically significant higher in grade II/III
Figure 4. Statistically significant associations between ADC values,
Ki-67 levels, and cell density. (a) Scatterplot for ADCmean and Ki-67
values. Ki-67 was negatively associated with ADCmean (r = −0.61,
P b .001). (b) Scatterplot for ADCmin and cell count values. ADCmin
correlated statistically significant with cell count (r=−0.44, P= .002).
Table 3. Correlations between DWI and Histopathological Findings in Grade I Meningioma
Parameter Cell Count Ki-67, %
ADCmin, ×10
−3 mm2s−1 r = −0.41
P = .008
r = −0.20
P = .195
ADCmean, ×10
−3 mm2s−1 r = −0.22
P = .158
r = −0.50
P = .001
NADC r =−0.23
P = .138
r = −0.55
P = .001
The significant correlations are given in boldface.
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P = .001).
Ki-67 was negatively associated with ADCmean (r = −0.61, P =
.001) (Figure 4a) and NADC (r = −0.60, P = .001) (Table 2). No
significant correlations between cell count and ADCmean (r = −0.20,
P = .164) or NADC (r = −0.25, P = .079) were found in the total
collective of meningeomas (Table 2). The identified correlations were
different in grade I and grade II/III tumors (Tables 3 and 4).Table 2. Correlations between DWI and Histopathological Findings in the Total Collective of
Meningiomas
Parameter Cell Count Ki-67, %
ADCmin, ×10
−3 mm2s−1 r = −0.44
P = .002
r = −0.22
P = .129
ADCmean, ×10
−3 mm2s−1 r = −0.20
P = .164
r = −0.61
P = .001
NADC r = −0.25 P = .079 r = −0.60
P = .001
The significant correlations are given in boldface.ADCmin correlated statistically significantly with cell count (r = −0.44,
P = .002) (Figure 4b) but not with Ki-67 (r = −0.22, P = .129) (Table 2).
Furthermore, the association between ADCmin and cell count was
stronger in grade II/III tumors (r = −0.79, P = .036) versus grade I
meningiomas (r = −0.41, P = .008) (Table 4).
An ADCmean value of less than 0.85 × 10
−3 mm2s−1 was
determined as the threshold in differentiating between grade I and
grade II/III meningiomas (sensitivity, 72.9%; specificity, 73.1%;
accuracy, 73.0%; Youden index, 0.571). ROC analysis showed that
the area under the curve was 0.809 (Figure 5a). The positive and
negative predictive values were 33.3% and 96.8%, respectively.
The same ADCmean value (≤0.85 × 10−3 mm2s−1) was estimated
as the threshold in differentiating between tumors with Ki-67 level
≥5% and meningiomas with low proliferation index (Ki-67 b5%).
This threshold yielded a sensitivity of 70.6%, a specificity of 81.2%,
an accuracy of 77.6%, and a Youden index of 0.518 (Figure 5b). The
area under the curve was 0.791. The positive and negative predictive
values were 66.6% and 83.9%, respectively.
Discussion
Previously, there were several reports to characterize meningiomas by
DWI [17–22]. For example, Sanverdi et al. analyzed 177 different
meningiomas and identified no significant difference between the
mean ADC ratios of benign, atypical, and malignant tumors [17].
Similar results were reported also in the study of Pavlisa et al.
investigating 26 patients [20]. However, Hakyemez et al. found in
their analysis of 39 patients with meningioma that the mean ADC
value of benign tumors was significant higher than the ADC value of
atypical/malignant meningiomas, namely, 1.17 ± 0.21 × 10−3 mm2s−1
and 0.75 ± 0.21 × 10−3 mm2s−1, respectively (P b .001) [18].
In addition, other authors also showed that atypical and malignant
meningiomas had lower ADC values compared with benign lesions [19,21].
There were only three reports in which DWI was correlated with
histopathological findings, such as cell count and proliferation index
in meningiomas [21,22,27]. Tang et al. identified a statistically
significant correlation (r = −0.33, P = .0039) between ADC and
Ki-67 in low-grade and high-grade meningiomas [21]. Ginat et al.,
however, analyzed high-grade meningiomas and found no correlation
between ADC and Ki-67 [22]. Also, Fatima et al. could not identify
any association between ADC and Ki-67 level [27]. However, Fatima
et al. found that ADC was negatively associated (r = −0.53, P = .02)Table 4. Correlations between DWI and Histopathological Findings in Grade II/III Meningioma
Parameter Cell Count Ki-67, %
ADCmin, ×10
−3 mm2s−1 r = −0.786
P = .036
r = −0.505
P = .247
ADCmean, ×10
−3 mm2s−1 r = 0.143
P = .760
r = −0.748
P = .053
NADC r = −0.252
P = .585
r = −0.189
P = .685
The significant correlations are given in boldface.
Figure 5. Use of ADCmean values in distinguishing between benign
and atypical/malignantmeningiomas. (a) ROC curve for use of ADCmean
values in distinguishing high-grademeningiomas frombenign tumors.
The threshold ADC value is less than 0.85 × 10−3 mm2s−1.
Sensitivity = 72.9%, specificity = 73.1%, accuracy = 73.0%. The
area under the curve is 0.809. The positive and negative predictive
values are 33.3% and 96.8%, respectively. (b) ROC curve for use of
ADCmean values in distinguishing meningiomas with high Ki-67
(≥5%) from meningiomas with low proliferation potential (Ki-67
b5%). The threshold ADC value is less than 0.85 × 10−3 mm2s−1.
Sensitivity = 70.6%, specificity = 81.2%, accuracy = 77.6%. The
area under the curve is 0.791. The positive and negative predictive
values were 66.6% and 83.9%, respectively.
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ADC values (min or mean, but not both values) in characterization of
meningiomas. In addition, different methods of ADC estimation
were performed. It may also explain controversial results of previous
reports. In addition, Ginat et al. analyzed high-grade tumors [22],
whereas in the analysis of Tang et al., most tumors were low-grade
meningiomas [21]. Fatima et al. provided no data regarding tumor
grading in their investigation [27].In our study, different associations between DWI findings and
histopathological parameters were identified. Firstly, Ki-67 was
negatively associated with ADCmean and NADC values. Secondly,
NADC and ADCmean correlated well with tumor grade but not with
cell count. Thirdly, ADCmin was negatively associated with cell count
of the investigated tumors but not with tumor grade. In accordance
with these findings, we found no differences in cell count between
benign and atypical/malignant tumors.
Our results also showed that the meningioma subgroups differed in
their relationships between several ADC and histopathological
parameters. For example, the identified significant correlation
between ADCmin and cell count was stronger in high-grade
meningiomas than in benign tumors. Furthermore, our study
suggested that different ADC parameters reflected different histo-
pathological findings in meningiomas. Our analysis confirms the
hypothesis of Chen et al., who found in their meta-analysis that
ADCmin is more related to tumor cellularity that ADCmean [28].
A key question is how the identified findings can be helpful to
distinguish benign meningiomas from grade II/III tumors. As seen,
the use of an ADCmean value of less than 0.85 × 10
−3 mm2s−1 can
differentiate grade I from grade II/III meningiomas. Furthermore, the
identified threshold ADCmean value is also helpful to diagnose tumors
with high proliferation potential.
Previously, Tang et al. performed a similar analysis [21]. The
author suggested an ADC cutoff of less than 0.70 × 10−3 mm2s−1 to
differentiate aggressive meningiomas from low-grade tumors. In
addition, they postulated an ADC cutoff of greater than 0.85 × 10−3
mm2s−1 to identify low-grade meningiomas. However, both
threshold values had a very low sensitivity (29%) [21].
Our study has several limitations. Firstly, it is retrospective.
Secondly, it includes 49 tumors, and only 7 of these tumors had a
grade higher than grade I. Greater numbers of high-grade tumors are
needed to study the associations between DWI features and
histological factors in different meningioma subgroups.
In conclusion, our analysis showed several associations between different
DWI findings and histopathological parameters. Grade II/III tumors had
statistically significant lower ADCmean values than grade I meningiomas.
ADCmean values correlated negatively with tumor proliferation index and
ADCmin with tumor cell count. Furthermore, these associations were
different in several meningioma grades. ADCmean can be used for
distinguishing between benign and atypical/malignant meningiomas.
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